Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Didanosine
Also marketed in the EU under the name(s): Didanosin, Didanosin Aurobindo, Didanosina Aurobindo, Didanosine Aurobindo
Active substance: Didanosine
Indication: Didanosine is indicated in combination with other antiretroviral drugs for the treatment of HIV-1 infected patients.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2013 Referral EMEA/H/A-29/1367 (2013)8335 of 20/11/2013